628284-75-3 Usage
Uses
Used in Medicinal Chemistry:
6-FLUORO-4-HYDROXY-3-NITROQUINOLINE is used as a pharmaceutical candidate for its anti-microbial, anti-cancer, and anti-inflammatory properties. Its unique structure allows it to interact with various biological targets, making it a promising agent for the development of new drugs to treat a range of diseases.
Used in Drug Development:
In the pharmaceutical industry, 6-FLUORO-4-HYDROXY-3-NITROQUINOLINE is utilized as a lead compound in the discovery and optimization of novel therapeutic agents. Its diverse biological activities and chemical properties facilitate the design of drugs with improved efficacy, selectivity, and safety profiles.
Used in Research:
6-FLUORO-4-HYDROXY-3-NITROQUINOLINE serves as a valuable research tool in the study of biological pathways and mechanisms. Its ability to modulate various cellular processes makes it useful for investigating the roles of specific proteins, enzymes, and signaling pathways in health and disease.
Used in Organic Synthesis:
As a building block in the synthesis of complex organic molecules, 6-FLUORO-4-HYDROXY-3-NITROQUINOLINE is employed in the chemical industry for the creation of advanced materials, pharmaceuticals, and other specialty chemicals. Its unique structural features and reactivity contribute to the development of innovative synthetic strategies and products.
Further research and testing are necessary to fully explore the potential uses and effects of 6-FLUORO-4-HYDROXY-3-NITROQUINOLINE, ensuring its safe and effective application in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 628284-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,8,2,8 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 628284-75:
(8*6)+(7*2)+(6*8)+(5*2)+(4*8)+(3*4)+(2*7)+(1*5)=183
183 % 10 = 3
So 628284-75-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H5FN2O3/c10-5-1-2-7-6(3-5)9(13)8(4-11-7)12(14)15/h1-4H,(H,11,13)
628284-75-3Relevant articles and documents
CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES
-
Page/Page column 71; 72; 83; 84, (2018/09/28)
The present invention provides novel cyclic substituted imidazo[4,5- c]quinoline derivatives of Formula (I), and the pharmaceutically acceptable salts thereof, wherein R1, R2, R4, R5, R6, X and Z are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of Formula I and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.
1H-IMIDAZO[4,5-c]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES
-
Page/Page column 56-57, (2008/06/13)
The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoloquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.